Research progress of Claudin-low breast cancer

Claudin-low breast cancer (CLBC) is a subgroup of breast cancer discovered at the molecular level in 2007. Claudin is one of the primary proteins that make up tight junctions, and it plays crucial roles in anti-inflammatory and antitumor responses as well as the maintenance of water and electrolyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chenglong, Xu, Anqi, Ma, Xiaoling, Yao, Yanfei, Zhao, Youmei, Wang, Chunyan, Chen, Ceshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613467/
https://www.ncbi.nlm.nih.gov/pubmed/37904877
http://dx.doi.org/10.3389/fonc.2023.1226118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613467/
https://www.ncbi.nlm.nih.gov/pubmed/37904877
http://dx.doi.org/10.3389/fonc.2023.1226118

Ejemplares similares